1 Gestational diabetes mellitus |
3 |
502 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.43 [0.29, 0.64] |
2 Fasting OGTT |
3 |
502 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.20 [‐0.28, ‐0.12] |
3 One hour OGTT |
3 |
502 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.68 [1.00, ‐0.37] |
4 Two hour OGTT |
3 |
502 |
Mean Difference (IV, Random, 95% CI) |
‐0.75 [‐1.07, ‐0.43] |
5 Hypertensive disorders of pregnancy |
2 |
398 |
Risk Ratio (M‐H, Random, 95% CI) |
0.43 [0.02, 8.41] |
6 Caesarean section |
2 |
398 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.95 [0.76, 1.19] |
7 Weight gain during pregnancy |
2 |
411 |
Mean Difference (IV, Random, 95% CI) |
0.64 [‐0.41, 1.70] |
8 Relevant biomarker changes associated with the intervention |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
8.1 Total cholesterol |
1 |
48 |
Mean Difference (IV, Fixed, 95% CI) |
‐47.29 [‐52.87, ‐41.71] |
8.2 Low density lipoprotein |
1 |
48 |
Mean Difference (IV, Fixed, 95% CI) |
‐33.50 [‐39.71, ‐27.29] |
8.3 High density lipoprotein |
1 |
48 |
Mean Difference (IV, Fixed, 95% CI) |
‐13.79 [‐18.91, ‐8.67] |
8.4 Triglycerides |
1 |
48 |
Mean Difference (IV, Fixed, 95% CI) |
‐39.33 [‐44.00, ‐34.66] |
9 Adverse effects of intervention |
2 |
245 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
10 Supplementary insulin |
2 |
398 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.48 [0.11, 2.09] |
11 Gestational age at birth |
2 |
398 |
Mean Difference (IV, Random, 95% CI) |
5.50 [‐7.24, 18.24] |
12 Preterm birth (less than 37 weeks' gestation) |
2 |
398 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.45 [0.17, 1.14] |
13 Macrosomia |
2 |
398 |
Risk Ratio (M‐H, Random, 95% CI) |
0.35 [0.02, 6.37] |
14 Birthweight |
2 |
398 |
Mean Difference (IV, Random, 95% CI) |
‐60.47 [‐265.21, 144.26] |
15 Shoulder dystocia |
2 |
398 |
Risk Ratio (M‐H, Random, 95% CI) |
2.33 [0.12, 44.30] |
16 Respiratory distress syndrome |
1 |
197 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.99 [0.06, 15.60] |
17 Neonatal hypoglycaemia |
2 |
398 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.36 [0.01, 8.66] |